Sign In
Buy GENE
$0.765
+0 (+0%)
At Close: Jan 15, 2025
Lexeo Therapeutics Announces $80 Million Equity Financing to Further Advance Development of Transformative Genetic Medicines for Cardiovascular Diseases
What Regeneron's Purchase Of 23andMe Means For Your Genetic Privacy
04:35pm, Wednesday, 21'st May 2025
Regeneron Pharmaceuticals announced on Monday it will acquire bankrupt genomics firm 23andMe for $256 million through a bankruptcy auction, promising to maintain ethical standards in handling sensitiv
-- Initial positive data from Phase 1/2 clinical trial of PM359 in CGD provide clinical proof-of-concept for Prime Editing as a transformative gene editing technology -- -- On-track to file IND and/or
Tenaya Therapeutics to Highlight Capsid Engineering, Gene Editing and Manufacturing Research at the ASGCT 28th Annual Meeting
08:30am, Tuesday, 13'th May 2025
Advancements Lay the Groundwork for Future Genetic Medicines for Rare and Prevalent Forms of Heart Disease Advancements Lay the Groundwork for Future Genetic Medicines for Rare and Prevalent Forms of
New patent covers a treatment method for a broad spectrum of alcohol-related disorders, including additional conditions associated with alcohol use New patent covers a treatment method for a broad spe
Abeona Surges After FDA Clears First Gene Therapy For Severe Genetic Skin Disease
04:41pm, Wednesday, 30'th Apr 2025
Abeona Therapeutics Inc.'s ABEO stock traded higher on Wednesday.
SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a peer-reviewed publication in Genome Research demonstrating that optical genome Mapping (OGM) can
Dublin, April 11, 2025 (GLOBE NEWSWIRE) -- The "Genetic Screening Testing for Preventive Health Market - A Global and Regional Analysis: Focus on Test Type, Technology, Application, End User and Count
Fifty 1 Labs, Inc. Celebrates Groundbreaking SpaceX, NASA, and ISS Yeast Experiment by Subsidiary Genetic Networks
09:42am, Tuesday, 01'st Apr 2025
Groundbreaking Yeast Experiment from Dr. Nislow's lab on Last Night's SpaceX Fram2 Mission Advances Space-Based Biotechnology Groundbreaking Yeast Experiment from Dr. Nislow's lab on Last Night's Spac
Soleno Therapeutics Secures FDA Approval For Its First Commercial Drug For Rare Genetic Disorder
08:11am, Thursday, 27'th Mar 2025
The U.S. Food and Drug Administration (FDA) on Wednesday approved Soleno Therapeutics, Inc.'s SLNO Vykat XR (diazoxide choline) extended-release tablets, previously referred to as DCCR, for hyperphagi
23andMe's Bankruptcy Sparks Privacy Concerns Over Genetic Database Of 15 Million Customers
02:45pm, Tuesday, 25'th Mar 2025
On Sunday, human genetics and biotechnology company 23andMe Holding Co ME voluntarily filed for Chapter 11 bankruptcy to enable a sale process to maximize its business value.
Genetic testing firm 23andMe files for bankruptcy
11:49am, Monday, 24'th Mar 2025
US genetic testing company 23andMe has filed for bankruptcy and is looking for a buyer, after rejecting a takeover offer from its resigning CEO.
23andMe Is Bankrupt. Here's What You Need to Know About Your Genetic Data
11:23am, Monday, 24'th Mar 2025
The genetic testing company, which plans to try to sell all of its assets, holds biological information on millions of people.
23andMe Launches New Homocysteine (MTHFR-Related) Genetic Report and Accompanying Lab Test
07:30am, Friday, 21'st Mar 2025
Provides 23andMe+ Premium members with highly requested insight into their likelihood of developing slightly elevated homocysteine levels Provides 23andMe+ Premium members with highly requested insigh
Can-Fite to Initiate Phase II Study in the Rare Genetic Disease Lowe Syndrome with Piclidenoson
09:00am, Wednesday, 19'th Mar 2025
FDA & EMA approvals for rare genetic diseases are fast and require clinical studies with small number of patients
